B. O'Rourke

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

H. Eichler, G. Hirsch, S. Garner, 2012, Clinical pharmacology and therapeutics.

Recognizing that Evidence is Made, not Born

I. M. Chen, H. Eichler, G. Hirsch, 2019, Clinical pharmacology and therapeutics.

The new definition of health technology assessment: A milestone in international collaboration

W. Oortwijn, Tara Schuller, B. O'Rourke, 2020, International Journal of Technology Assessment in Health Care.

The Ohio COVID-19 Survey: Preliminary Findings and Their Use During the Pandemic

E. Seiber, B. O'Rourke, Selasi Attipoe, 2021 .

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

W Goettsch, D Samaha, S. Schneeweiss, 2015, Clinical pharmacology and therapeutics.

Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?

H. Eichler, L. Sansom, S. Tunis, 2014, Therapeutic innovation & regulatory science.

The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

T. Merlin, Tara Schuller, B. O'Rourke, 2019, International Journal of Technology Assessment in Health Care.

Announcing the New Definition of Health Technology Assessment.

W. Oortwijn, Tara Schuller, B. O'Rourke, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.